Not all patients want faster cancer drug approvals without certainty they work
Patients with cancer could be willing to wait for greater certainty of the benefit of new cancer drugs before they are ...
US FDA declines full approval for Intercept's liver disease drug
The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, ...
Florida Gov. DeSantis' Canadian drug import plan goes nowhere after FDA approval
Florida sued the FDA over what it said was a "reckless delay" in approving its drug importation plan. Now, nearly a year ...
Cure Today9d
FDA Approves Danziten for Leukemia Subset That Does Not Require Fasting
Danziten, a new formulation of nilotinib, may improve treatment adherence in patients with Philadelphia chromosome-positive ...
US FDA approves PTC Therapeutics' gene therapy for ultra-rare disorder
The U.S. Food and Drug Administration approved PTC Therapeutics' gene therapy to treat a potential fatal enzyme deficiency ...
Targeted Oncology8d
FDA Approves Revumenib in KMT2A-Rearranged Acute Leukemia
Revumenib is now an FDA-approved treatment for adult and pediatric patients with relapsed/refractory KMT2A-rearranged acute ...